Health Care & Life Sciences » Biotechnology | Seres Therapeutics Inc.

Seres Therapeutics Inc.

Seres Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
40.8 M
Public Float
14.32 M
Seres Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.33
Market Cap
$210.06 M
Shares Outstanding
69.91 M
Public Float
20.75 M

Profile

Address
200 Sidney Street
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.serestherapeutics.com
Updated 07/08/2019
Seres Therapeutics, Inc. is a microbiome therapeutics platform company, which engages in the development of biological drugs. It focuses on implementing microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. The company was founded by Geoffrey von Maltzahn, David A.

Financials

View All

Roger J. Pomerantz
Chairman, President & Chief Executive Officer
Meryl Zausner
Director